Here, APOA5 demonstrated a strong protective effect against MI and MetS, consistent with findings that APOA5 knockout mice display a fourfold elevation in plasma triglyceride levels41, a significant risk factor for ACVD42. The gene discussed is APOA5; the disease is metabolic syndrome.